ondansetron hydrochloride
ondansetron hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ondansetron hydrochloride; Generic name: ONDANSETRON HYDROCHLORIDE; Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs.
| Brand name | ondansetron hydrochloride |
|---|---|
| Generic name | ONDANSETRON HYDROCHLORIDE |
| Manufacturer | NCS HealthCare of KY, LLC dba Vangard Labs |
| Used for | 1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisp |
| Dosage | 2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults and pediatrics (2) Patients with severe hepatic impairment: do not exceed a total daily dose of 8 mg ( 2.2 , 8.6 ) 2.1 Dosage The recommended dosage regimens for adult and pediatric patients are described in Table 1 and Table 2, respectively. Corresponding doses of ondansetron tablets may be used interchangeably. Table 1: Adult Recommended Dosage Regimen for Prevention of Nausea and Vomiting Indicat |
| Active ingredient(s) | ONDANSETRON HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00327696-c496-4c83-a63e-9e29fd6246d4 |